Answers to common questions about ibogaine treatment, safety, effectiveness, and legal status.
Ibogaine is illegal in the United States, where it's classified as a Schedule I controlled substance with no recognized medical use. It's also illegal in many European countries, Australia, and parts of Asia.
Treatment is available in countries where ibogaine is legal or unregulated, including Mexico, Costa Rica, Canada (with physician oversight), South Africa, New Zealand (with restrictions), and Brazil.
Seeking treatment in countries where ibogaine is legal is not generally a crime. However, attempting to bring ibogaine back into a country where it's illegal can result in serious criminal charges. Never attempt to transport ibogaine across international borders.
Yes, since ibogaine treatment requires traveling to countries where it's legal. US citizens need a valid passport for Mexico, Costa Rica, Canada, South Africa, and other destinations offering ibogaine treatment.
Studies and clinical observations suggest that ibogaine can significantly reduce withdrawal symptoms and cravings in opioid-dependent individuals. Reported success rates range from 50-80% for opioid addiction, though these figures vary by study and depend heavily on aftercare.
Important: Success depends not just on the ibogaine experience itself, but on proper aftercare, integration support, and ongoing recovery efforts. Ibogaine is not a magic cure—it's a tool that can create a window of opportunity for recovery.
The acute ibogaine experience typically lasts 24-48 hours. Most treatment centers recommend arriving 1-2 days early for medical screening and staying 3-5 days after for initial integration support. Total stay is usually 5-7 days to 2 weeks.
The ibogaine experience is often described as a "waking dream" or panoramic life review. During the acute phase (4-8 hours), many people experience:
The experience is generally considered therapeutic rather than recreational. Many find it intense and challenging but ultimately meaningful.
For some individuals, a single ibogaine treatment successfully interrupts addiction long enough for lasting behavioral change. However, about one-third of those treated require additional sessions, and long-term success usually requires:
Some evidence suggests ibogaine can help with alcohol dependence by reducing cravings and providing psychological insights. However, alcohol withdrawal can be medically dangerous, and patients should never stop drinking abruptly before treatment without medical supervision. A proper detox may be required before ibogaine treatment.
Clinical observations suggest ibogaine may help interrupt stimulant addiction, though research is more limited than for opioids. The mechanism appears to involve resetting dopamine systems that stimulants have disrupted. Success rates appear lower than for opioid addiction, and more research is needed.
Yes. Ibogaine carries serious risks, including the risk of death. The primary danger is cardiac arrhythmia, particularly in individuals with pre-existing heart conditions. Deaths have occurred during ibogaine treatment, primarily due to cardiac complications or improper screening.
This is why proper medical screening, ECG testing, and supervised treatment are absolutely essential. Never attempt ibogaine without appropriate medical oversight.
You should NOT take ibogaine if you have:
No. This combination can be fatal. Opioid maintenance medications (methadone, buprenorphine/Suboxone) combined with ibogaine significantly increase the risk of cardiac arrhythmia and death.
Most treatment centers require patients to be off opioid maintenance medications for a significant period before ibogaine treatment. The specific washout period varies by medication and should only be done under medical supervision.
Treatment costs vary by location and facility:
See our Treatment Costs page for a complete breakdown including travel expenses.
No. Because ibogaine is not legal in the United States, insurance companies do not cover treatment. All costs must be paid out-of-pocket.
Most centers recommend staying 3-7 days total. The ibogaine experience itself takes 24-48 hours, and additional days allow for medical recovery and initial integration support. Some patients choose to stay longer for more comprehensive aftercare.
You should plan for at least 1-2 weeks of recovery time after treatment. While the acute effects last only a day or two, many people feel "reset" and benefit from a period of reflection before returning to normal activities. Some experience lingering neurochemical effects (from noribogaine) that can last weeks.
The information on this site provides educational content only. For personalized guidance:
For authoritative information, consult the National Institutes of Health ibogaine research database and the Global Ibogaine Research Initiative.
Remember: ibogaine carries serious risks. No website can replace professional medical advice. Always consult qualified healthcare providers before making treatment decisions.